Shanghai Kehua Bio-engineering Co Ltd (002022):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Shanghai Kehua Bio-engineering Co Ltd (002022) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9997
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Shanghai Kehua Bio-engineering Co Ltd (KHB) is a medical device company that develops, manufactures and markets in vitro diagnostic devices and related products. The company’s major product portfolio includes enzyme immunoassay kits, clinical chemistry reagents, PCR kits, rapid test kits, chemiluminescence reagents; and laboratory instruments such as clinical chemistry analyzers, electrolyte analyzers, microplate readers, nucleic acid extractors and automatic chemiluminescence analyzers. It is one of the global suppliers of WHO, UNICEF, PEPFAR, and the Clinton HIV/AIDS Initiative. The company has sales supports facilities in major cities in China and it markets its products in China and across the world through distributors. KHB is headquartered in Shanghai, China.

Shanghai Kehua Bio-engineering Co Ltd (002022) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Shanghai Kehua Bio-engineering Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shanghai Kehua Bio-engineering Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Shanghai Kehua Bio-engineering Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shanghai Kehua Bio-engineering Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Shanghai Kehua Bio-engineering Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Shanghai Kehua Bio-engineering Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Shanghai Kehua Bio-engineering Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Shanghai Kehua to Acquire Diagnostic Assets from Altergon Italia 11
Acquisition 12
Shanghai Kehua Bio-Engineering Plans to Acquire 55% Stake in Guangdong-Based Biotechnology Company for USD19.3 Million 12
KHB Shanghai Kehua Bio-Engineering Acquires Technogenetics USD20.6 Million 13
Shanghai Kehua to Acquire Technogentics from Bouty Healthcare 14
Shanghai Kehua Bio-engineering Co Ltd – Key Competitors 15
Shanghai Kehua Bio-engineering Co Ltd – Key Employees 16
Shanghai Kehua Bio-engineering Co Ltd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Shanghai Kehua Bio-engineering Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Shanghai Kehua Bio-engineering Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shanghai Kehua Bio-engineering Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Shanghai Kehua Bio-engineering Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shanghai Kehua Bio-engineering Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Shanghai Kehua Bio-engineering Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Shanghai Kehua Bio-engineering Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Shanghai Kehua to Acquire Diagnostic Assets from Altergon Italia 11
Shanghai Kehua Bio-Engineering Plans to Acquire 55% Stake in Guangdong-Based Biotechnology Company for USD19.3 Million 12
KHB Shanghai Kehua Bio-Engineering Acquires Technogenetics USD20.6 Million 13
Shanghai Kehua to Acquire Technogentics from Bouty Healthcare 14
Shanghai Kehua Bio-engineering Co Ltd, Key Competitors 15
Shanghai Kehua Bio-engineering Co Ltd, Key Employees 16
Shanghai Kehua Bio-engineering Co Ltd, Subsidiaries 17

List of Figures
Shanghai Kehua Bio-engineering Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Shanghai Kehua Bio-engineering Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Shanghai Kehua Bio-engineering Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Shanghai Kehua Bio-engineering Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Shanghai Kehua Bio-engineering Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shanghai Kehua Bio-engineering Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Shanghai Kehua Bio-engineering Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shanghai Kehua Bio-engineering Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Shanghai Kehua Bio-engineering Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Shanghai Kehua Bio-engineering Co Ltd (002022):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ICU Medical Inc (ICUI)-医療機器分野:企業M&A・提携分析
    Summary ICU Medical Inc (ICU Medical) is a medical device company which develops, manufactures, distributes and sells devices used for infusion therapy, cancer diagnosis and treatment and critical care applications. The company’s major products include needle free vascular access devices, closed sys …
  • Fuji Chemical Industry Co Ltd:戦略・SWOT・企業財務分析
    Fuji Chemical Industry Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Fuji Chemical Industry Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Mizuho Financial Group Inc
    Mizuho Financial Group Inc - Strategy, SWOT and Corporate Finance Report Summary Mizuho Financial Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Terumo Cardiovascular Systems Corporation:製品パイプライン分析
    Summary Terumo Cardiovascular Systems Corporation (TCSC), a subsidiary of Terumo Corporation, is a provider of medical equipment and devices for cardiac and vascular surgeries. It produces hardware products including heart-lung machines and intra-operative monitoring systems for cardiac surgeries. I …
  • NV Energy Inc:電力:M&Aディール及び事業提携情報
    Summary NV Energy Inc (NVE) is an energy holding company, which provides a wide range of services through its principal subsidiaries, Nevada Power Co and Sierra Pacific Power Co. NVE delivers electricity to residential, commercial and industrial customers. It also sells electricity and natural gas t …
  • Empire Energy Group Ltd (EEG):企業の財務・戦略的SWOT分析
    Summary Empire Energy Group Ltd (EEGL), formerly Imperial Corp Ltd is an oil and gas company that offers exploration and production programs. The company produces and develops oil and gas assets; and has interest in onshore oil and gas fields in Mid Con property and Appalachia property. It has onsho …
  • High Arctic Energy Services Inc (HWO):石油・ガス:M&Aディール及び事業提携情報
    Summary High Arctic Energy Services Inc (High Arctic) is an oil and gas company that provides drilling services and equipment for rentals. The company provides services such as drilling services, matting and equipment rentals, snubbing services and nitrogen services. It offers equipment rentals of l …
  • Spire Inc (SR):企業の財務・戦略的SWOT分析
    Spire Inc (SR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • AnaMar AB-製薬・医療分野:企業M&A・提携分析
    Summary AnaMar AB (AnaMar), a subsidiary of Koncentra Holding AB, discovers, develops and commercializes therapeutic strategies to treat debilitating inflammation, fibrosis and pain. The company develops drug candidates from several chemical classes that concentrates on the receptors and shows poten …
  • Perseus Mining Limited:企業の戦略・SWOT・財務情報
    Perseus Mining Limited - Strategy, SWOT and Corporate Finance Report Summary Perseus Mining Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Media General, Inc.:企業のM&A・事業提携・投資動向
    Media General, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Media General, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • SFS Group AG:企業の戦略・SWOT・財務情報
    SFS Group AG - Strategy, SWOT and Corporate Finance Report Summary SFS Group AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Chori Co Ltd (8014):企業の財務・戦略的SWOT分析
    Chori Co Ltd (8014) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Oil India Ltd (OIL):石油・ガス:M&Aディール及び事業提携情報
    Summary Oil India Ltd (OIL) is an integrated upstream petroleum company which explores, develops, and produces crude oil and natural gas. It has petroleum exploration licenses in India; and exploration and production blocks across Venezuela, Gabon, Myanmar, Nigeria, Libya, Mozambique, Bangladesh, th …
  • Tempur Sealy International, Inc.:企業の戦略・SWOT・財務情報
    Tempur Sealy International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tempur Sealy International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Mondi Plc (MNDI):企業の戦略的SWOT分析
    Mondi Plc (MNDI) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Serodus ASA:製薬・医療:M&Aディール及び事業提携情報
    Summary Serodus ASA (Serodus) is a drug development company that develops treatments for unmet clinical needs in the areas of diabetes and diabetic comorbidities. The company’s pipeline products include SER150DN, an anti-inflammatory compound under development for diabetic nephropathy; SER130AMI, an …
  • Hemispherx Biopharma Inc (HEB):医療機器:M&Aディール及び事業提携情報
    Summary Hemispherx Biopharma Inc (Hemispherx) is a biopharmaceutical company, which develops, manufactures and commercializes drug therapies for the treatments of viral and immune based chronic disorders. It offers products for the treatment of various diseases such as hepatitis B, hepatitis C, chro …
  • Balaji Amines Ltd (BALAMINES):企業の財務・戦略的SWOT分析
    Balaji Amines Ltd (BALAMINES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Trillium Therapeutics Inc (TRIL):製薬・医療:M&Aディール及び事業提携情報
    Summary Trillium Therapeutics Inc (Trillium), formerly Neurogenesis Biotech Corp, is a clinical stage immuno-oncology company, which develops novel therapies for the treatment of cancer. The company’s lead program, TTI-621, a SIRPaFc fusion protein is being developed for hematological malignancies. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆